8.3(top 2%)
impact factor
15.4K(top 1%)
papers
609.3K(top 1%)
citations
221(top 1%)
h-index
8.4(top 2%)
impact factor
17.8K
all documents
639.3K
doc citations
325(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticlesCancer Letters20041,728
2Circular RNA: A new star of noncoding RNAsCancer Letters20151,457
3Tumor microenvironment and therapeutic responseCancer Letters20171,267
4Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticlesCancer Letters20061,251
5Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in miceCancer Letters20081,044
6Long non-coding RNAs: A new frontier in the study of human diseasesCancer Letters20131,041
7Ionizing radiation-induced metabolic oxidative stress and prolonged cell injuryCancer Letters20121,019
8The insulin-like growth factor system and cancerCancer Letters20031,002
9Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findingsCancer Letters1987958
10Anti-tumour and antioxidant activity of natural curcuminoidsCancer Letters1995956
11Curcumin and cancer: An “old-age” disease with an “age-old” solutionCancer Letters2008951
12Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteinsCancer Letters2008929
13HDAC family: What are the cancer relevant targets?Cancer Letters2009893
14Circulating tumor cells (CTC) detection: Clinical impact and future directionsCancer Letters2007863
15Anthocyanins and their role in cancer preventionCancer Letters2008840
16Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOCCancer Letters1995793
17Chemopreventive and therapeutic effects of curcuminCancer Letters2005771
18p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agentsCancer Letters2014765
19Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapyCancer Letters2020753
20DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosisCancer Letters2013720
21Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticalsCancer Letters2017704
22Bovine milk-derived exosomes for drug deliveryCancer Letters2016630
23Multitargeted cancer prevention by quercetinCancer Letters2008622
24Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapyCancer Letters2007605
25Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancerCancer Letters2017603
26Tumor microenvironment: Sanctuary of the devilCancer Letters2015601
27Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growthCancer Letters2013597
28Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decadeCancer Letters2016595
29The anti-inflammatory potential of berberine in vitro and in vivoCancer Letters2004593
30Helicobacter pylori-induced gastric inflammation and gastric cancerCancer Letters2014580
31Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approachesCancer Letters2014577
32The role of CXC chemokines and their receptors in cancerCancer Letters2008565
33Potential anticancer activity of turmeric (Curcuma longa)Cancer Letters1985562
34Multi-targeted therapy of cancer by genisteinCancer Letters2008554
35Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapyCancer Letters2008548
36The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanismCancer Letters2015541
37Oxidative stress, DNA methylation and carcinogenesisCancer Letters2008530
38Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expressionCancer Letters2013524
39Angiopoietins in angiogenesisCancer Letters2013523
40Role of aberrant crypt foci in understanding the pathogenesis of colon cancerCancer Letters1995522
41Role of chemokines in tumor growthCancer Letters2007516
42Anoikis resistance and tumor metastasisCancer Letters2008509
43The inflammatory chemokines CCL2 and CCL5 in breast cancerCancer Letters2008502
44Cancer related inflammation: The macrophage connectionCancer Letters2008499
45Cytochrome P450-mediated metabolism of estrogens and its regulation in humanCancer Letters2005488
46c-Met as a target for human cancer and characterization of inhibitors for therapeutic interventionCancer Letters2005488
47Nrf2 as a novel molecular target for chemopreventionCancer Letters2005476
48Role of chemopreventive agents in cancer therapyCancer Letters2004463
49Multi-targeted prevention of cancer by sulforaphaneCancer Letters2008457
50Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpeneCancer Letters2009456